Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $182,053 - $214,262
834 New
834 $212,000
Q2 2022

Aug 12, 2022

SELL
$234.74 - $275.42 $4,694 - $5,508
-20 Reduced 1.53%
1,289 $318,000
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $690 - $752
-3 Reduced 0.23%
1,309 $329,000
Q3 2021

Nov 15, 2021

SELL
$232.72 - $256.47 $29,090 - $32,058
-125 Reduced 8.7%
1,312 $323,000
Q2 2021

Aug 16, 2021

SELL
$232.65 - $254.58 $11,632 - $12,729
-50 Reduced 3.36%
1,437 $349,000
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $24,601 - $27,229
-106 Reduced 6.65%
1,487 $362,000
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $16,644 - $18,445
-75 Reduced 4.5%
1,593 $399,000
Q3 2020

Nov 16, 2020

SELL
$215.77 - $276.76 $10,788 - $13,838
-50 Reduced 2.91%
1,668 $388,000
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $54,975 - $65,852
-250 Reduced 12.7%
1,718 $411,000
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $652 - $738
-3 Reduced 0.15%
1,968 $496,000
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $506,058 - $609,505
-2,456 Reduced 55.48%
1,971 $492,000
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $60,804 - $76,605
297 Added 7.19%
4,427 $997,000
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $19,577 - $21,504
84 Added 2.08%
4,130 $1.08 Million
Q2 2018

Aug 13, 2018

SELL
$208.1 - $233.85 $5,826 - $6,547
-28 Reduced 0.69%
4,046 $969,000
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $226,211 - $264,537
1,101 Added 37.03%
4,074 $883,000
Q4 2017

Feb 15, 2018

BUY
$189.0 - $222.64 $561,897 - $661,908
2,973
2,973 $636,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track First Commonwealth Financial Corp Portfolio

Follow First Commonwealth Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Commonwealth Financial Corp with notifications on news.